Abstract
The growing interest in the diagnosis of bipolar disorder in youth has sparked subsequent interest and controversy related to the appropriate treatment of the disorder in this population. As such, authoritative bodies like the American Academy of Child and Adolescent Psychiatry (AACAP) have recently published practice parameters regarding the treatment of early-onset bipolar disorder. These guidelines advocate for first-line, primary psychopharmacological treatment with adjunct psychosocial therapy (McClellan et al., 2007).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
A comprehensive discussion regarding the multitude of potential adverse effects of each of the medications used to treat bipolar disorder is beyond the scope of this text. However, it is crucial for school psychologists and other educational professionals to be aware of these effects. It is recommended that these professionals educate themselves through available individuals (e.g., psychiatrist, nurse) and resources (e.g., medication websites) on a case-by-case basis, and to ensure that a child’s educational team is consistently reminded of these effects.
- 2.
It seems to be common practice to develop a draft of the IEP, including goals, prior to an IEP meeting. The US Department of Education strongly recommends that if a draft is constructed, parents are provided a copy prior to the IEP meeting, so that they have an opportunity to review the recommendations and are better able to engage in full discussion of the proposals for the IEP (34 C. F. R. § 300, pp. 46678; Department of Education, August 14, 2006). In the case of a student with bipolar disorder, this is a particularly important consideration, as these IEP meetings may be fairly involved.
References
Angst, J., Stassen, H. H., Clayton, P. J., & Angst, J. (2002). Mortality of patients with mood disorders: Follow-up over 34–38 years. Journal of Affective Disorders, 68, 167–181. doi:10.1016/S0165-0327(01)00377-9.
Chang, K. D. (2008). The use of atypical antipsychotics in pediatric bipolar disorder. Journal of Clinical Psychiatry, 69(Suppl. 4), 4–8. www.psychiatrist.com.
Coletti, D. J., Leigh, E., Galleli, K. A., & Kafantaris, V. (2005). Patterns of adherence to treatment in adolescents with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 15, 913–917. doi:10.1089/cap.2005.15.913.
Consoli, A., Deniau, E., Huynh, C., Purper, D., & Cohen, D. (2007). Treatments in child and adolescent bipolar disorder. European Child & Adolescent Psychiatry, 16, 187–198. doi:10.1007/s00787-006-0587-7.
Correll, C. U. (2008). Weight gain and metabolic abnormalities in pediatric bipolar disorder. In B. Geller & M. P. DelBello (Eds.), Treatment of bipolar disorder in children and adolescents (pp. 361–391). New York, NY: Guilford Press.
DelBello, M. P., Schwiers, M. L., Rosenberg, H. L., & Strakowski, S. M. (2002). A double-blind, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1216–1223. doi:10.1097/00004583-200210000-00011.
Drotar, D., Greenley, R. N., Demeter, C. A., McNamara, N. K., Stansbrey, R. J., Calabrese, J. R., et al. (2007). Adherence to pharmacological treatment for juvenile bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 831–839. doi:10.1097/chi.0b013e31805c7421.
Duffy, F. F., Narrow, W. E., Rae, D. S., West, J. C., Zarin, D. A., Rubio-Stipec, M., et al. (2005). Concomitant pharmacotherapy among youths treated in routine psychiatric practice. Journal of Child and Adolescent Psychopharmacology, 15, 12–25. doi:10.1089/cap.2005.15.12.
Findling, R. L., Frazier, J. A., Kafantaris, V., Kowatch, R., McClellan, J., Pavuluri, M., et al. (2008). The collaborative lithium trials (CoLT): Specific aims, methods, and implementation. Child and Adolescent Psychiatry and Mental Health, 2, 21–34. doi:10.1186/1753-2000-2-21.
Findling, R. L., & Pavuluri, M. N. (2008). Lithium. In B. Geller & M. P. DelBello (Eds.), Treatment of bipolar disorder in children and adolescents (pp. 43–68). New York: Guilford.
Food and Drug Administration (2007a). FDA proposes new warnings about suicidal thinking, behavior in young adults who take antidepressant medications. FDA News. Retrieved from http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html
Food and Drug Administration (2007b). Revisions to product labeling. Retrieved from http://www.fda.gov/cder/drug/antidepressants/antidepressants_label_change_2007.pdf
Frank, E. (2005). Treating bipolar disorder: A clinician’s guide to interpersonal and social rhythm therapy. New York, NY: Guilford Press.
Frazier, J. A., Bregman, H. R., & Jackson, J. A. (2008). Atypical antipsychotics in the treatment of early-onset bipolar disorder. In B. Geller & M. P. DelBello (Eds.), Treatment of bipolar disorder in children and adolescents (pp. 69–108). New York, NY: Guilford Press.
Fristad, M. A., Davidson, K. H., & Leffler, J. M. (2007). Thinking-feeling-doing: A therapeutic technique for children with bipolar disorder and their parents. Journal of Family Psychotherapy, 18, 81–103. doi:10.1300/J085v18n04_06.
Fristad, M. A., Verducci, J. S., Walters, K., & Young, M. E. (2009). Impact of multifamily psychoeducational psychotherapy in treating children aged 8 to 12 years with mood disorders. Archives of General Psychiatry, 66, 1013–1020. doi:10.1001/archgenpsychiatry.2009.112.
Ghaziuddin, N., Kutcher, S. P., Knapp, P., Bernet, W., Arnold, V., Beitchman, J., et al. (2004). Practice parameter for use of electroconvulsive therapy with adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1521–15399. doi:10.1097/01.chi.0000142280.87429.68.
Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., Erkens, J. A., et al. (2007). Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. The American Journal of Psychiatry, 164, 1356–1363. doi:10.1176/appi.ajp.2007.07030454.
Goldberg, J. F., Perlis, R. H., Ghaemi, S. N., Calabrese, J. R., Bowden, C. L., Wisniewski, S., et al. (2007). Adjunctive antipressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: Findings from the STEP-BD. The American Journal of Psychiatry, 164, 1348–1355. doi:10.1176/appi.ajp.2007.05122032.
Goldstein, T. R., Axelson, D. A., Birmaher, B., & Brent, D. A. (2007). Dialectical behavior therapy for adolescents with bipolar disorder: A 1-year open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 820–830. 10.1097.chi.0b013e31805c1613.
Gracious, B. L., Chirieac, M. C., Costescu, S., Finucane, T. L., Youngstrom, E. A., & Hibbeln, J. R. (2010). Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disorders, 12, 142–154. doi:10.1111/j.1399-5618.2010.00799.x.
Hlastala, S. A., Kotler, J. S., McClellan, J. M., & McCauley, E. A. (2010). Interpersonal and social rhythm therapy for adolescents with bipolar disorder: Treatment development and results from an open trial. Depression and Anxiety, 27, 457–464. doi:10.1002/da.20668.
Individuals with Disabilities Education Improvement Act. (2004). Retrieved from www.ed.gov/about/offices/list/osers/osep/index.html
Jairam, R., Srinath, S., Girimaji, S. C., & Seshadri, S. P. (2004). A prospective 4–5 year follow-up of juvenile onset bipolar disorder. Bipolar Disorders, 6, 386–394. doi:10.1111/j.1399-5618.2004.00149.x.
Jensen, P. S., Buitelaar, J., Pandina, G. J., Binder, C., & Haas, M. (2007). Management of psychiatric disorders in children and adolescents with atypical antipsychotics: A systematic review of published clinical trials. European Child & Adolescent Psychiatry, 16, 104–120. doi:10.1007/s00787-006-0580-1.
Joshi, P. T., & Robb, A. S. (2008). Polycystic ovary syndrome. In B. Geller & M. P. DelBello (Eds.), Treatment of bipolar disorder in children and adolescents (pp. 333–360). New York, NY: Guilford Press.
Knowles, S., & Shear, N. H. (2009a). Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Dermatologic Therapy, 22, 441–451. doi:10.1111/j.1529-8019.2009.01260.x.
Kowatch, R. A. (2008). Mood stabilizers. In B. Geller & M. P. DelBello (Eds.), Treatment of bipolar disorder in children and adolescents (pp. 109–125). New York, NY: Guilford Press.
Knowles, S., & Shear, N. H. (2009b). Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Dermatologic Therapy, 22, 441–451. doi:10.1111/j.1529-8019.2009.01260.x.
Maayan, L., & Correll, C. U. (2011). Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 21, 517–535. doi:10.1089/cap.2011.0015.
McClellan, J., Kowatch, R., Findling, R. L., Bernet, W., Bukstein, O., Beithchman, J., et al. (2007). Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 107–125. doi:10.1016/j.jaac.2011.09.019.
Mennuti, R. B., Christner, R. W., & Freeman, A. (Eds.). (2012). Cognitive-behavioral interventions in educational settings: A handbook for practice––second edition. New York, NY: Routledge.
Miklowitz, D. J. (2008). Bipolar disorder: A family-focused treatment approach. New York, NY: Guilford Press.
Miklowitz, D. J., Axelson, D. A., Birmaher, B., George, E. L., Taylor, D. O., Schneck, C. D., et al. (2008). Family-focused treatment for adolescents with bipolar disorder: Results of a 2-year randomized trial. Archives of General Psychiatry, 65, 1053–1061. doi:10.1001/archpsyc.65.9.1053.
Miklowitz, D. J., Chang, K. D., Taylor, D. O., George, E. L., Singh, M. K., Schneck, C. D., et al. (2011). Early psychosocial intervention for youth at risk for bipolar I or II disorder: A one-year treatment development trial. Bipolar Disorders, 13, 67–75. doi:10.1111/j.1399-5618.2011.00890.x.
Miklowitz, D. J., Goodwin, G. M., Bauer, M. S., & Geddes, J. R. (2008). Common and specific elements of psychosocial treatments for bipolar disorder: A survey of clinicians participating in randomized trials. Journal of Psychiatric Practice, 14, 77–85. doi:10.1097/01.pra.0000314314.94791.c9.
Mockenhaupht, M., Viboud, C., Dunant, A., Naldi, L., Halevy, S., Bavinck, J. N. B., et al. (2008). Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. Journal of Investigative Dermatology, 128, 35–44. doi:10.1038/sj.jiid.5701033.
Mondimore, F. M. (2006). Bipolar disorder: A guide for patients and families (2nd ed.). Baltimore, MD: Johns Hopkins Press Health.
Morris, C. D., Miklowitz, D. J., & Waxmonsky, J. A. (2007). Family-focused treatment for bipolar disorder in adults and youth. Journal of Clinical Psychology: In Session, 63, 433–445. doi:10.1002/jclp.20359.
O’Neill, R. E., Horner, R. H., Albin, R. W., Sprague, J. R., Storey, K., & Newton, J. S. (1997). Functional assessment and program development for problem behavior: A practical handbook (2nd ed.). Pacific Grove, CA: Brooks/Cole.
Patel, N. C., DelBello, M. P., Keck, P. E., & Strakowski, S. M. (2005). Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 15, 938–946. doi:10.1089/cap.2005.15.938.
Pavuluri, M. N. (2008). What works for bipolar kids: Help and hope for parents. New York, NY: Guilford Press.
Pavuluri, M. N., Graczyk, P. A., Henry, D. B., Carbray, J. A., Heidenreich, J., & Miklowitz, D. J. (2004a). Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: Development and preliminary results. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 528–537. doi:10.1097/00004583-200405000-00006.
Pavuluri, M. N., Graczyk, P. A., Henry, D. B., et al. (2004b). RAINBOW: Two programs combined may be better than one for pediatric BD. The Brown University Child and Adolescent Behavior Letter, 20(7), 5–7.
Pavuluri, M. N., Henry, D. B., Moss, M., Mohammed, T., Carbray, J. A., & Sweeney, J. A. (2009). Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 19, 75–82. doi:10.1089/cap.2008.0107.
Pfeifer, J. C., Kowatch, R. A., & DelBello, M. P. (2010). Pharmacotherapy of bipolar disorder in children and adolescents: Recent progress. CNS Drugs, 24, 575–593. doi:10.2165/11533110-000000000-00000.
Post, R. M., Leverich, G. S., Kupka, R. W., Keck, P. E., McElroy, S., Altshuler, L. L., et al. (2010). Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. The Journal of Clinical Psychiatry, 71, 864–872. doi:10.4088/JCP.08m04994yel.
Preston, J., & Johnson, J. (2008). Clinical psychopharmacology made ridiculously simple (5th ed.). Miami, FL: MedMaster.
Reikert, K. A., & Drotar, D. (2000). Adherence to medical treatment in pediatric chronic illness: Critical issues and unanswered questions. In D. Drotar (Ed.), Promoting adherence to treatment in pediatric chronic illness: Concepts, methods, and interventions (pp. 201–231). Mahwah, NJ: Erlbaum.
Smarty, S., & Findling, R. L. (2007). Psychopharmacology of pediatric bipolar disorder: A review. Psychopharmacology, 191, 39–54. doi:10.1007/s00213-006-0569-y.
West, A. E., Henry, D. B., & Pavuluri, M. N. (2007). Maintenance model of integrated psychosocial treatment in pediatric bipolar disorder: A pilot feasibility study. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 205–212. doi:10.1097/01.chi.0000246068.85577.d7.
West, A. E., Jacobs, R. H., Westerholm, R., Adabel, L., Carbray, J., Heidenreich, J., et al. (2009). Child and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: Pilot study of group treatment format. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 18, 239–246. www.cacap-acpea.org/.
Wozniak, J., Biederman, J., Mick, E., Waxmonsky, J., Hantsoo, L., Best, C., et al. (2007). Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial. European Neuropsychopharmacology, 17, 440–447. doi:10.1016/j.euroneuro.2006.11.006.
Young, M. E., & Fristad, M. A. (2007). Evidence based treatments for bipolar disorder in children and adolescents. Journal of Contemporary Psychotherapy, 37, 157–164. doi:10.1007/s10879-007-9050-4.
Zito, J. M., Derivan, A. T., Kratochvil, C. J., Safer, D. J., Fegert, J. M., & Greenhill, L. L. (2008). Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child and Adolescent Psychiatry and Mental Health, 2, 24–35. doi:10.1186/1753-2000-2-24.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hart, S.R., Brock, S.E., Jeltova, I. (2014). Treatment of Bipolar Disorder in Children and Adolescents. In: Identifying, Assessing, and Treating Bipolar Disorder at School. Developmental Psychopathology at School. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-7585-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7585-9_7
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-7584-2
Online ISBN: 978-1-4614-7585-9
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)